本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Forte BioSciences Inc

32.61
+2.959.93%
成交量:21.22萬
成交額:673.25萬
市值:4.08億
市盈率:-7.43
高:33.00
開:29.46
低:29.25
收:29.66
52周最高:33.00
52周最低:4.90
股本:1,252.69萬
流通股本:926.19萬
量比:1.51
換手率:2.29%
股息:- -
股息率:- -
每股收益(TTM):-4.3909
每股收益(LYR):-12.1671
淨資產收益率:-110.72%
總資產收益率:-58.07%
市淨率:4.86
市盈率(LYR):-2.68

資料載入中...

2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/01

重要事件披露

8-K - Current report
2022/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/18

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/02

重要事件披露

8-K - Current report
2021/09/16

超過5%披露

Forte Biosciences, Inc.
2021/09/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/04

重要事件披露

8-K - Current report
2021/06/03

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals